Subscribe

Sheila W. Sawyer, Esq.

Articles by Sheila W. Sawyer, Esq.

Regulatory Focus on Off-Label Promotion Is Rising

BySheila W. Sawyer, Esq.,Tanielle D. Henriques, Esq., Waller Lansden Dortch & Davis LLP

May 4th 2009

While FDA guidance on appropriate medical communication has evolved, US Dept. of Justice attention the practice is intensifying

Latest Updated Articles

Regulatory Focus on Off-Label Promotion Is Rising
May 4th 2009

Trending on Pharmaceutical Commerce

Philip Sclafani: Will PBM Reform Actually Lower Net Drug Costs?

How GLP-1 Growth and Specialty Drugs Are Driving Cost Pressure

Report: GLP-1s, Oncology to Drive Drug Spending Surge in 2027

Why Packaging Is Now a Frontline Issue In Pharma Supply Chains

How the US Section 301 Probe Targets Germany's Drug Pricing